Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Items 301–400 of 1,005
Bai, J., Zhang, H., Yang, Z., Li, P., Liu, B., Li, D., Liang, S., Wang, Q., Li, Z., Zhang, J., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.039 · Cited by 28
Glycometabolism reprogramming: Implications for cardiovascular diseases
Peng, G., Yan, J., Chen, L., & Li, L. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.03.003 · Cited by 28
Omentin roles in physiology and pathophysiology: an up-to-date comprehensive review
Hussein, A. A., Ahmed, N. A., Sakr, H. I., Atia, T. A., & Ahmed, O. M. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2283685 · Cited by 30
“Furthermore, it has been noted that people who have superior glucose metabolism and increased iS – a state that can be attained through things like exercise and weight loss – had greater levels of omentin (galicia-garcia et al. 2020).”
Ghatan, S., van Rooij, J., van Hoek, M., Boer, C. G., Felix, J. F., Kavousi, M., Jaddoe, V. W. V., Sijbrands, E. J. G., Medina‐Gómez, C., Rivadeneira, F., et al. (2024) · Genome Medicine · doi:10.1186/s13073-023-01255-7 · Cited by 32
“Metabolic trait GWAS for colocalization were selected based on the following criteria: whether the trait (i) is an established clinical risk factor for T2D [22], (ii) is known to be involved in T2D pathophysiology [23], and (iii) has a significant genetic correlation with T2D [4, 24].”
MethodKumar, D., Aggarwal, N., Kumar, V., Chopra, H., Marwaha, R. K., & Sharma, R. (2024) · Future Medicinal Chemistry · doi:10.4155/fmc-2023-0203 · Cited by 26
Kumari, B., Kumari, U., Singh, D. K., Husain, G. M., Patel, D. K., Shakya, A., Singh, R. B., Modi, G. P., & Singh, G. K. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303262653231120043819 · Cited by 30
Zhang, C., Fang, B., Zhang, N., Zhang, Q., Niu, T., Zhao, L., Sun, E., Wang, J., Xiao, R., He, J., et al. (2024) · Nutrients · doi:10.3390/nu16111691 · Cited by 26
Shahabudin, S., Azmi, N. S., Lani, M. N., Mukhtar, M., & Hossain, M. S. (2024) · Mycoses · doi:10.1111/myc.13753 · Cited by 49
Konings, L. A. M., Matute, L. M., Boeren, A. M. P., van de Luitgaarden, I. A. T., Dirksmeier-Harinck, F., de Knegt, R. J., Tushuizen, M. E., Grobbee, D. E., Holleboom, A. G., & Cabezas, M. C. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70003 · Cited by 34
Emergence of microneedles as a potential therapeutics in diabetes mellitus
Zahoor, I., Singh, S., Behl, T., Sharma, N., Naved, T., Subramaniyan, V., Fuloria, S., Fuloria, N. K., Bhatia, S., Al‐Harrasi, A., et al. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17346-0 · Cited by 34
Wu, Y., Dong, L., Song, Y., Wu, Y., Zhang, Y., & Wang, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.152 · Cited by 29
Delpino, F. M., Figueiredo, L. M., da Silva, T. G., & Flores, T. R. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.02.004 · Cited by 28
Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients
Thomas, S., Ouhtit, A., Al-Khatib, H. A., Eid, A. H., Mathew, S., Nasrallah, G. K., Emara, M. M., Maslamani, M. A. R. S. A., & Yassine, H. M. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.03.002 · Cited by 30
Kosmalski, M., Pękala‐Wojciechowska, A., Sut, A., Pietras, T., & Luzak, B. (2022) · Nutrients · doi:10.3390/nu14051083 · Cited by 28
“Type 2 diabetes (T2DM) is one of the most common metabolic diseases in the world, and its development is primarily associated with insulin resistance (IR) of peripheral tissues and insufficient insulin production by pancreatic beta cells [1].”
BackgroundAmeliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases
Li, K., Xiao, Y., Bian, J., Han, L., He, C., El-Omar, E. M., Gong, L., & Wang, M. (2022) · Nutrients · doi:10.3390/nu14122549 · Cited by 29
“Diabetes mellitus (DM) is a chronic metabolic disease characterized by elevated blood sugar levels over time leading to damage to the heart, vasculature, eyes, kidneys, and nerves [70].”
BackgroundRole of microbial dysbiosis in the pathogenesis of Alzheimer's disease
Susmitha, G., & Kumar, R. K. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109478 · Cited by 28
Razliqi, R. N., Ahangarpour, A., Mard, S. A., & Khorsandi, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121770 · Cited by 30
The circadian rhythm: an influential soundtrack in the diabetes story
Hariri, A., Mirian, M., Zarrabi, A., Kohandel, M., Amini-Pozveh, M., Aref, A. R., Tabatabaee, A., Prabhakar, P. K., & Sivakumar, P. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1156757 · Cited by 30
“Pathogenesis of T2DM is fueled by inducing insulin resistance in skeletal muscle, liver, and fat so that insulin signaling is disturbed (31).”
BackgroundPost-Translational Modifications and Diabetes
Sharma, C., Hamza, A., Boyle, E., Donu, D., & Cen, Y. (2024) · Biomolecules · doi:10.3390/biom14030310 · Cited by 30
Xu, H., Li, W., Huang, L., He, X., Xu, B., He, X., Chen, W., Wang, Y., Xu, W., Wang, S., et al. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100337 · Cited by 28
“heart, blood vessels, eyes, kidneys, andnerves (2).”
Nutrición animal: Texto de formación universitaria
Huanca, B. R. (2023) · Instituto Universitario de Innovación Ciencia y Tecnología Inudi Perú eBooks · doi:10.35622/inudi.b.090 · Cited by 26
ZJU Index as a Predictive Tool for Diabetes Incidence: Insights from a Population-Based Cohort Study
Wu, C., Loh, Y. H., Huang, H., & Xu, C. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s446042 · Cited by 28
Netayawijit, P., Chansanam, W., & Sorn-in, K. (2025) · Healthcare · doi:10.3390/healthcare13202588 · Cited by 52
Xenos, D., Mancinetti, F., Mecocci, P., & Boccardi, V. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102955 · Cited by 29
Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update
Palmer, E. S., Irwin, N., & O'Harte, F. P. M. (2022) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514221074679 · Cited by 30
Yu, S., Liu, L., Bu, T., Zheng, J., Wang, W., Wu, J., & Liu, D. (2022) · Food & Function · doi:10.1039/d1fo03941e · Cited by 25
Sensitive Electrochemical Non-Enzymatic Detection of Glucose Based on Wireless Data Transmission
Kim, Y., Chinnadayyala, S. R., Le, H. T. N., & Cho, S. (2022) · Sensors · doi:10.3390/s22072787 · Cited by 25
“Diabetes mellitus, instigated primarily by the lack of insulin, is a common human health problem identified by increased levels of glucose concentration in the blood [1].”
BackgroundRole of platelet-derived growth factor c on endothelial dysfunction in cardiovascular diseases
Grismaldo, A., Sobrevía, L., & Morales, L. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130188 · Cited by 26
“According to its aetiology, T1DM refers to an early-onset autoimmune form, and T2DM corresponds to a late-onset non-autoimmune form [34,38].”
BackgroundTheurey, P., Thang, C., Pīrāgs, V., Mari, A., Pacini, G., Bolze, S., Hallakou‐Bozec, S., & Fouqueray, P. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.371 · Cited by 27
The mitigative effect of isorhamnetin against type 2 diabetes via gut microbiota regulation in mice
Li, J., Yuan, H., Zhao, Z., Li, L., Li, X., Zhu, L., Wang, X., Sun, P., & Xiao, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1070908 · Cited by 28
“Type 2 diabetes mellitus (T2DM) is among the most common metabolic disorders and is mainly caused by defective insulin secretion by pancreatic β-cells and a loss of insulin sensitivity in target tissues (1).”
BackgroundLittig, J. P. B., Moellmer, R., Agrawal, D. K., & Rai, V. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i1.35 · Cited by 26
Mathur, A., Taurin, S., & Alshammary, S. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s392161 · Cited by 29
“Introduction Type 2 diabetes mellitus (T2DM) is a heterogeneous disease characterized by the dysregulation of lipids, carbohydrates, and proteins and associated with impaired insulin secretion, insulin resistance, or both.(1) In comparison to Type 1 diabetes, also known as insulin-dependent diabetes, T2DM has a higher…”
BackgroundRole of MicroRNA-502-3p in Human Diseases
Devara, D., Choudhary, Y., & Kumar, S. (2023) · Pharmaceuticals · doi:10.3390/ph16040532 · Cited by 28
“T2DM is primarily caused by defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond to insulin [37].”
BackgroundFrom diabetic hyperglycemia to cerebrovascular Damage: A narrative review
Machado, R. S., Mathias, K., Joaquim, L. D. S., de Quadros, R. W., Petronilho, F. C., & Rezin, G. T. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148611 · Cited by 26
Alhawday, F., Alminderej, F. M., Ghannay, S., Hammami, B., Albadri, A. E. A. E., Kadri, A., & Aouadi, K. (2024) · Molecules · doi:10.3390/molecules29020305 · Cited by 25
“…and T2D, in which genetic predispositions, overweight, physical inactivity, and other environmental factors work together to generate a variable degree of insulin resistance and dysfunction of β -pancreatic cells, leads to hyperglycemia as the main pathophysiological consequence [16,17].”
CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases
Heim, X., Joshkon, A., Bermudez, J., Bachelier, R., Dubrou, C., Boucraut, J., Foucault‐Bertaud, A., Leroyer, A. S., Dignat‐George, F., Blot‐Chabaud, M., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8120592 · Cited by 26
“During the course of the disease, an increase in plasma osmolarity occurs, which induces diuresis with polyuropolydypsia [34].”
BackgroundVasincu, A., Rusu, R.-N., Ababei, D. C., Neamţu, M., Arcan, O. D., Macadan, I., Chiriac, S. I. B., Bild, W., & Bild, V. (2023) · Biomedicines · doi:10.3390/biomedicines11061667 · Cited by 30
Ghannay, S., Aldhafeeri, B. S., Ahmad, I., Albadri, A. E. A. E., Patel, H., Kadri, A., & Aouadi, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25911 · Cited by 25
“More than 65% of people with diabetes die from the disease with T2DM (Noninsulin-dependent diabetes mellitus) accounting for more than 90% is by far the most often prominent of them, which results from the combination of genetic factors, environmental and lifestyle factors [17 – 19].”
BackgroundAzizi, S., Dehghani, M., & Nabizadeh, R. (2024) · International Journal of Environmental Health Research · doi:10.1080/09603123.2024.2391993 · Cited by 30
“It is clear that additional empirical and epidemiological studies are necessary to gain a more comprehensive comprehension of the detrimental effects of fine particulate air pollution on the susceptibility to T2DM (Galicia-Garcia et al. 2020).”
Nicchio, I. G., Cirelli, T., Quil, L. C. D. C., Camilli, Â. C., Scarel‐Caminaga, R. M., & Leite, F. R. M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116908 · Cited by 29
Sebők, J., Édel, Z., Váncsa, S., Farkas, N., Kiss, S., Erőss, B. M., Török, Z., Balogh, G. E., Balogi, Z., Nagy, R., et al. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.2003445 · Cited by 31
Ranuve, M. S., & Mohammadnezhad, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-060896 · Cited by 24
Kashyap, B., Saikia, K., Samanta, S. K., Thakur, D., Banerjee, S. K., Borah, J. C., & Talukdar, N. C. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115788 · Cited by 28
Grismaldo, A., Zamudio-Rodriguez, J. A., Barreto, A., Sanabria‐Barrera, S. M., Iglesias, J., & Morales, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054394 · Cited by 26
“Metabolic diseases, including diabetes, are considered the main risk factor for the development of cardiovascular diseases (CVD) [1,2].”
BackgroundShen, S., Wei, J., Kang, W., & Wang, T. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04356-4 · Cited by 29
“The primary pathological process underlying type 2 diabetes mellitus (T2DM) is islet dysfunction, which is characterized by impaired insulin secretion [41].”
BackgroundAhmad, M. F., Ahmad, F. A., Hasan, N., Alsayegh, A. A., Hakami, O., Bantun, F., Tasneem, S., Alamier, W. M., Babalghith, A. O., Aldairi, A. F., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131644 · Cited by 37
Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus
Sharma, P., Singh, S., Thakur, V., Sharma, N., & Grewal, A. S. (2021) · Obesity Medicine · doi:10.1016/j.obmed.2021.100329 · Cited by 33
Fisiopatología y alteraciones clínicas de la diabetes mellitus tipo 2: revisión de literatura
Fernández, C. I. J., Pereira, Y. A. M., Chang, A. S. O., Olmedo, S. I. G., & Gaete, M. C. A. (2022) · Nova · doi:10.22490/24629448.6184 · Cited by 66
Basak, S., Murmu, A., Matore, B. W., Roy, P. P., & Singh, J. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100160 · Cited by 48
Ratan, Y., Rajput, A., Pareek, A., Pareek, A., Kaur, R., Sonia, S., Kumar, R., & Singh, G. (2024) · Biomedicines · doi:10.3390/biomedicines12071390 · Cited by 33
Zaki, S., Alam, M. F., Sharma, S., El‐Ashker, S., Ahsan, M., & Nuhmani, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133910 · Cited by 35
“Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and hyperglycemia, leading to various complications, including car-J diovascular disease and neuropathy [1].”
BackgroundKuryata, O. V., Akimov, O. Y., Ryabushko, M. М., Kostenko, H., Kostenko, V., Mishchenko, A. V., Nazarenko, S., Solovyova, N. V., & Kostenko, V. О. (2024) · iScience · doi:10.1016/j.isci.2024.111477 · Cited by 23
Yadegar, A., Mohammadi, F., Seifouri, K., Mokhtarpour, K., Yadegar, S., Hazaveh, E. B., Seyedi, S. A., Rabizadeh, S., Esteghamati, A., & Nakhjavani, M. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02526-5 · Cited by 27
“IR has been found to promote atherosclerosis and the formation of lipid lesions which has been considered an important risk factor for CAD in patients with diabetes [36, 37].”
Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus
He, Y., Chen, M.-T., Wang, T., Zhang, M.-M., Li, Y., Wang, H., & Ding, N. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113720 · Cited by 23
El‐Huneidi, W., Anjum, S., Bajbouj, K., Abu‐Gharbieh, E., & Taneera, J. (2021) · Molecules · doi:10.3390/molecules26175167 · Cited by 25
Senescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age?
Henson, S. M., & Aksentijević, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716517 · Cited by 25
Chitosan-Encapsulated Nano-selenium Targeting TCF7L2, PPARγ, and CAPN10 Genes in Diabetic Rats
Abo-Zaid, O. A., El-Sonbaty, S. M., Hamam, N. M. A., Farrag, M. A., & Kodous, A. S. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03140-7 · Cited by 25
The WWOX/HIF1A Axis Downregulation Alters Glucose Metabolism and Predispose to Metabolic Disorders
Baryła, I., Styczeń-Binkowska, E., Płuciennik, E., Kośla, K., & Bednarek, A. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063326 · Cited by 23
“In type 2 diabetes, multiple aspects of glucose homeostasis are disturbed which leads to hyperglycemia [68,69].”
BackgroundFongsodsri, K., Thaipitakwong, T., Rujimongkon, K., Kanjanapruthipong, T., Ampawong, S., Reamtong, O., & Aramwit, P. (2022) · Nutrients · doi:10.3390/nu14214538 · Cited by 27
“Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder and the most common found, making up over 90% of diabetes cases [1,2].”
BackgroundFu, X., Wang, Y., Cates, R. S., Li, N., Liu, J., Ke, D., Liu, J., Liu, H., & Yan, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1061507 · Cited by 25
Basic Concepts of Diabetics Mellitus for the Welfare of General Patients
Mohajan, D., & Mohajan, H. K. (2023) · Studies in Social Science & Humanities · doi:10.56397/sssh.2023.06.03 · Cited by 51
Li, R., Shokri, F., Lopez‐Rincon, A., Rivadeneira, F., Medina‐Gómez, C., & Ahmadizar, F. (2023) · Genes · doi:10.3390/genes14081572 · Cited by 24
“Alterations in the composition and activity of the gut microbiome (known as intestinal dysbiosis) can reduce short-chain fatty acid (SCFA) synthesis [6], which could damage the gut barrier integrity, influence pancreatic β-cell proliferation, and lessen insulin biosynthesis, thus boosting a rapid progression toward in…”
BackgroundSeyedmahalleh, M. H., Montazer, M., Ebrahimpour‐Koujan, S., & Azadbakht, L. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.006 · Cited by 24
“An excess of FFAs and blood glucose results in β -cell dysfunction through the progressing endoplasmic reticulum stress by stimulation of the apoptotic unfolded protein response mechanisms [9].”
BackgroundExperimental study on physical exercise in diabetes: pathophysiology and therapeutic effects
Messina, G., Alioto, A., Parisi, M. C., Mingrino, O. G. M., Corrado, D. D., Crescimanno, C., Kuliś, S., Şahin, F. N., Padua, E., Canzone, A., et al. (2023) · European Journal of Translational Myology · doi:10.4081/ejtm.2023.11560 · Cited by 39
“People with impaired glucose tolerance (IGT) or impaired fasting glycaemia (IFG) are at high risk of progressing to T2DM, although this is not inevitable 9 .”
BackgroundZahra, S., Saleem, M. K., Ejaz, K. F., Akbar, A., Jadoon, S. K., Hussain, S., Ali, A. I., Ifty, M., Jannati, S. Z., Armin, F., et al. (2024) · Medicine · doi:10.1097/md.0000000000039759 · Cited by 34
“[11, 12] Type 1 DM is expected to afflict children and adolescents, but type 2 DM is thought to affect middle-aged and older individuals who have chronic hyperglycemia as a result of poor lifestyle and nutritional factors.”
BackgroundProbiotics as Antioxidant Strategy for Managing Diabetes Mellitus and Its Complications
Viana, M. D. M., Santos, S. S., Cruz, A. B. O., de Jesus, M. V. A. C., Lauria, P. S. S., Lins, M. P., & Villarreal, C. F. (2025) · Antioxidants · doi:10.3390/antiox14070767 · Cited by 31
Серік, С., Mavrycheva, N., & Ченчік, Т. О. (2021) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2021.4.08 · Cited by 59
Considerations about Hypoxic Changes in Neuraxis Tissue Injuries and Recovery
Stoica, S. I., Bleoţu, C., Ciobanu, V., Ionescu, A. M., Albadi, I., Onose, G., & Munteanu, C. (2022) · Biomedicines · doi:10.3390/biomedicines10020481 · Cited by 23
“(Shahabipour, 2017) [88] Aβ proteins along with the decreased expression of neprilysin”
BackgroundThe genetics of bipolar disorder with obesity and type 2 diabetes
Miola, A., Filippis, E. D., Veldić, M., Ho, A. M., Winham, S. J., Mendoza, M., Romo‐Nava, F., Núñez, N. A., Gardea‐Resendez, M., Prieto, M. L., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.084 · Cited by 29
Motto, A. E., Lawson-Evi, P., & Eklu‐Gadegbeku, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113578 · Cited by 25
Szydełko, J., & Matyjaszek‐Matuszek, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010616 · Cited by 27
“Diabetic atherogenesis is a complex, multi-step process characterized by the infiltration of inflammatory cells, monocyte/macrophage activation, vascular smooth muscle cell (VSMC) differentiation, and platelet hyperactivity, along with dysfunctional endothelial cells (ECs) and endothelialto-mesenchymal transition (End…”
BackgroundInfluentialNik, W. N. F. H. W., Zulkeflee, H. A., Rahim, S. N. A., & Ismail, T. S. T. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i1.26 · Cited by 24
Overall Clinical Features of Type 2 Diabetes Mellitus With Respect to Gender
Ali, J., Haider, S. M. S., Ali, S. M., Haider, T., Anwar, A., & Hashmi, A. A. (2023) · Cureus · doi:10.7759/cureus.35771 · Cited by 28
“To achieve the desired glycemic target, oral hypoglycemic medications are becoming increasingly therapeutically necessary based on glycated Hb levels, average glycemia over 24 h, and other factors [9].”
BackgroundMahmoud, M., Juntunen, M., Adnan, A., Kummola, L., Junttila, I., Kelloniemi, M., Tyrväinen, T., Huhtala, H., Fattah, A. I. A. E., Amr, K. S., et al. (2023) · Stem Cells · doi:10.1093/stmcls/sxad021 · Cited by 23
Bartel, I., Koszarska, M., Strzałkowska, N., Tzvetkov, N. T., Wang, D., Horbańczuk, J. O., Wierzbicka, A., Atanasov, A. G., & Jóźwik, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119765 · Cited by 32
“After maturation, insulin is stored in granules until its release, caused by a high level of glucose [28].”
BackgroundHe, L., Li, Y., Niu, S., Bai, J., Liu, S., & Guo, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1184572 · Cited by 31
“, 2019), mitochondrial dysfunction, excess fatty acid, or lack of the cretin effect (Galicia-Garcia et al., 2020).”
BackgroundInfluentialRecent advancements on novel approaches of insulin delivery
Karmakar, S., Bhowmik, M., Laha, B., & Manna, S. (2023) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2023.100253 · Cited by 30
Wu, S., Wang, L., He, Y., Shi, F., Zhuang, H., Mei, L., & Qian, Y.-L. (2023) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2023.101802 · Cited by 25
Non-drug interventions of traditional Chinese medicine in preventing type 2 diabetes: a review
Liu, J., Yao, C., Wang, Y., Zhao, J., & Luo, H. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00854-1 · Cited by 24
“…are not fully understood, several risk factors, including a complex combination of genetic, metabolic and environmental factors, have shown strong relationships with it [20–22], such as family history [23], obesity [24, 25], unhealthy diet [26, 27], physical inactivity [28], and ethnicity [29, 30].”
BackgroundAL‐Bukhaiti, W. Q., Al‐Dalali, S., Li, H., Yao, L., Abed, S. M., Zhao, L., & Qiu, S. (2023) · Plant Foods for Human Nutrition · doi:10.1007/s11130-023-01118-x · Cited by 21
Azmi, A., Noori, M., Ghomi, M. K., Montazer, M. N., Iraji, A., Dastyafteh, N., Oliyaei, N., Khoramjouy, M., Rezaei, Z., Javanshir, S., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107106 · Cited by 22
Valvi, D., Christiani, D. C., Coull, B. A., Højlund, K., Nielsen, F., Audouze, K., Su, L., Weihe, P., & Grandjean, P. (2022) · SSRN Electronic Journal · doi:10.1016/j.envres.2023.115600 · Cited by 24
Gao, Y., Zhao, T., Lv, N., Liu, S., Yuan, T., Fu, Y., Zhao, W., & Zhu, B. (2024) · Endocrine · doi:10.1007/s12020-024-03828-x · Cited by 27
“This disorder, marked by insulin resistance and β -cell dysfunction, is linked to in fl ammation induced by overnutrition and environmental factors [2].”
Shao, W., Pan, B., Li, Z., Peng, R., Yang, W., Xie, Y., Han, D., Fang, X., Li, J., Zhu, Y., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.135096 · Cited by 24
Saikia, L., Barbhuiya, S. A. A., Saikia, K., Kalita, P., & Dutta, P. P. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266330678240821060623 · Cited by 27
Tao, W., Liu, D., Guo, Z., Han, P., Ma, Y., Wu, M., Zhang, R., & He, J. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122790 · Cited by 23
Darwish, R., Alcibahy, Y., Bucheeri, S., Albishtawi, A., Tama, M., Shetty, J. K., & Butler, A. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313169 · Cited by 31
“Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by a combination of insulin resistance (IR) and a decline in insulin production due to loss of pancreatic β -cells [1,2].”
Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease
Li, C., Wang, D., Jiang, Z., Gao, Y., Sun, L., Li, R., Chen, M., Lin, C., & Liu, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.961802 · Cited by 24
“The abnormal phosphorylation of insulin receptor (INSR) brings about IR (3).”
BackgroundSerhiyenko, V. A., Serhiyenko, L. M., Sehin, V. B., & Serhiyenko, A. A. (2022) · Endocrine Regulations · doi:10.2478/enr-2022-0031 · Cited by 23
Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review
Anshika, A., Pandey, R. K., Singh, L., Kumar, S., Singh, P. K., Pathak, M., & Jain, S. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00443-3 · Cited by 36
Firdaus, J. U., Siddiqui, N., Alam, O., Manaithiya, A., & Chandra, K. (2023) · Archiv der Pharmazie · doi:10.1002/ardp.202200421 · Cited by 22
Yu, M., Wu, S. L., Gong, C., & Chen, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1066279 · Cited by 206
“Indeed, skeletal muscle IR is considered as the most important extrapancreatic factor in T2DM pathogenesis (Song et al., 2013; Yaribeygi et al., 2019; Galicia-Garcia et al., 2020).”
BackgroundShi, C., Mammadova‐Bach, E., Li, C., Liu, D., & Anders, H. (2023) · The FASEB Journal · doi:10.1096/fj.202301316r · Cited by 26
Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications
Satyadev, N., Rivera, M. I., Nikolov, N. K., & Fakoya, A. O. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1241096 · Cited by 22
“Amongst these tissues, the three most critical to the development of T2DM are skeletal muscle, adipose tissue, and liver (DeFronzo and Tripathy, 2009; Galicia-Garcia et al., 2020).”
Cyclodextrin Host–Guest Recognition in Glucose-Monitoring Sensors
Javanbakht, S., Darvishi, S., Dorchei, F., Ghalehno, M. H., Dehghani, M., Pooresmaeil, M., Suzuki, Y., Ain, Q., Ruiz‐Rubio, L., Shaabani, A., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c03746 · Cited by 22
RETRACTED: Analysis of risk factors of infection in diabetic foot patients
Hsu, L., Li, L., & Poon, L. Y. (2023) · International Wound Journal · doi:10.1111/iwj.14411 · Cited by 27
RetractedHasan, I., Rainsford, K. D., & Ross, J. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01242-9 · Cited by 21
Hassan, I., Al‐Tamimi, J., Ebaid, H., Habila, M. A., Alhazza, I. M., & Rady, A. M. (2023) · Toxics · doi:10.3390/toxics11100867 · Cited by 22
“The disease is attributed to a multifactorial metabolic disorder characterized by either decreased insulin secretion and/or its action or reduced uptake by the target cells, leading to hyperglycemia [4].”
BackgroundNi, J., Wen, X., Wang, S., Zhou, X., & Wang, H. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103406 · Cited by 22
Bioactive Peptides from Legumes and Their Bioavailability
Indrati, R. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.99979 · Cited by 30
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.